Details of the Drug Formulations

General Information of Drug (ID: DMJFD2I)

• Drug Name: ABT-492 Drug Info
• Synonyms: Delafloxacin; 189279-58-1; ABT-492; WQ-3034; Abt 492; 1-(6-AMINO-3,5-DIFLUOROPYRIDIN-2-YL)-8-CHLORO-6-FLUORO-7-(3-HYDROXYAZETIDIN-1-YL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID; ABT492; RX-3341; UNII-6315412YVF; 6315412YVF; 1-(6-amino-3,5-difluoro-2-pyridyl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-quinoline-3-carboxylic acid; 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxoquinoline-3-carboxylic acid; Delafloxacin [USAN:INN]; Delafloxacinum; Delafloxacin (USAN)

Indication

Disease Entry	ICD 11	Status	REF
Bacterial infection	1A00-1C4Z	Phase 3	[1]

• Cross-matching ID:
  PubChem CID: 487101
  CAS Number: 189279-58-1
  TTD ID: D0V9BU
  INTEDE ID: DR1895
  ACDINA ID: D00175

Full List of Drug Formulations Containing This Drug

Delafloxacin 450 mg tablet

Company	Formulation ID	FDA Description
Melinta Therapeutics	F05288	Anhydrous citric acid; Magnesium palmitostearate; Sodium bicarbonate; Water; Sodium phosphate, monobasic, unspecified form; Povidone k30; Crospovidone (12 mpa.s at 5%); Microcrystalline cellulose

Delafloxacin Meglumine 300 mg For Injection

Company	Formulation ID	FDA Description
Melinta Therapeutics	F23417	Citric Acid Anhydrous; Crospovidone; Magnesium Stearate; Microcrystalline Cellulose; Povidone; Sodium Bicarbonate; Sodium Phosphate Monobasic Monohydrate

Delafloxacin Meglumine 450 mg tablet

Company	Formulation ID	FDA Description
Melinta Therapeutics	F23418	Edetate Disodium (Edta); Meglumine; Sulfobutylether--Cyclodextrin

References

• [1] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009417)